Synthetic Biologics Reports 2020 Second Quarter Operational Highlights and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. TMUS
7. SPY
8. CVS
9. UNH
10. AXP

Go back to Synthetic Biologics Reports 2020 Second Quarter Operational Highlights and Financial Results

Synthetic Biologics (SYN) Misses Q2 EPS by 2c

August 6, 2020 5:07 PM EDT

Synthetic Biologics (NYSE: SYN) reported Q2 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16).

"During the second quarter, we remained diligently focused on advancing our portfolio of GI and microbiome-focused clinical development programs while continuing to navigate the unprecedented global health and economic crisis sparked by the COVID-19 global pandemic," said Steven A. Shallcross, Chief Executive and Financial Officer of Synthetic Biologics. "We made significant progress positioning SYN-020, our orally... More